Recombinant 2019-nCoV Nucleocapsid Protein from ELK Biotechnology Read more ›
Recombinant 2019-nCoV Nucleocapsid Protein is a research-use recombinant protein from ELK Biotechnology preparation representing Recombinant 2019-nCoV Nucleocapsid Protein supplied as Lyophilized. Review the expression, purity, formulation and storage specifications below before selecting it for an assay or functional workflow.
Recombinant SARS-CoV-2 Nucleocapsid Protein is produced by our E.coli expression system and the target gene encoding Met1-Ala419 is expressed with a 6His tag at the N-terminus.
Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
| Delivery condition | The product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below. |
|---|
| Collaborator | ELK Biotechnology |
| Partner model | EPT266 |
| Target | Recombinant 2019-nCoV Nucleocapsid Protein |
| Research areas | Infectious Diseases, Molecular Biology |
| Reactivity | Product QC:C |
| Applications | Functional assay |
| Assay type | Recombinant protein |
| Purity | >95% by SDS-PAGE |
| Category | Purity | Endotoxin | Bioactivity |
|---|---|---|---|
| Product QC |
Collaborator meets ABMIUM quality standards and overall product performance standards have been met.
Quality management certification.
For research applications. Not for diagnostic use.
No customer reviews yet.
